Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 26.7.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2121DDipperam HCT 5 mg/160 mg/12,5 mg filmom obalené tablety (tbl flm 28x5 mg/160 mg/12,5 mg (blis.PVC/PVDC/Al))26.7.2022O
 26.7.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)28912Ospamox 750 mg filmom obalené tablety (tbl flm 14x750 mg (blis.PVC/PVDC/Al))26.7.2022O
 26.7.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)28913Ospamox 1000 mg filmom obalené tablety (tbl flm 14x1000 mg (blis.PVC/PVDC/Al))26.7.2022O
 26.7.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7709BDuloxetin Sandoz 30 mg (cps end 30x30 mg (blis.PVC/PE/PCTFE/Al))26.7.2022O
 26.7.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)89132PERINDASAN 4 mg/1,25 mg tablety (tbl 90x4 mg/1,25 mg (blis.Al/Al))26.7.2022O
 26.7.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)96168Sumatriptan Sandoz 50 mg tablety (tbl 6x50 mg (blis.Al/Al))26.7.2022O
 26.7.2022MEDOCHEMIE Ltd. (MOE)04089AMICOR 10 mg (tbl flm 30x10 mg (blis.Al/Al))1.8.2022R
 26.7.2022MEDOCHEMIE Ltd. (MOE)2214DMEDOVERT 20 mg/40 mg tablety (tbl 20x20 mg/40 mg (blis.PA/Al/PVC/Al))1.8.2022R
 26.7.2022MEDOCHEMIE Ltd. (MOE)67536ULCERAN 40 (tbl flm 10x40 mg (blis.PVC/Al))1.8.2022R
 25.7.2022Glenmark Pharmaceuticals s.r.o. (GLM-CZ)7052ATelmark Plus 80 mg/12,5 mg (tbl 90x80 mg/12,5 mg (blis.Al/Al))15.7.2022R
 25.7.2022medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)66509Carbomedac 10 mg/ ml infúzny koncentrát (con inf 1x15 ml/150 mg (liek.skl.jantár.))25.7.2022R
 25.7.2022Novartis Europharm Limited (NEH-IE)87609Revolade 50 mg filmom obalené tablety (tbl flm 28x50 mg (blis.PA/Al/PVC/Al))29.7.2022R
 25.7.2022Instituto Grifols, S.A. (GFO)45082Flebogamma DIF 50 mg/ml infúzny roztok (sol inf 1x100 ml/5 g (liek.skl.))25.7.2022R
 25.7.2022Merck Sharp & Dohme B.V. (MSD-NL)95505VARIVAX (plv iul 1x3 ml inj.l.s pr.(min.1350 PFU/ 0,5 ml)+1x1 ml nap.i.s.+2 ihly)15.7.2022O
 25.7.2022Glenmark Pharmaceuticals s.r.o. (GLM-CZ)3528DDesloratadine Glenmark 5 mg tablety (tbl 100x5 mg (blis.Al/Al))25.7.2022O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)